by Mike Masnick
Thu, Oct 18th 2007 6:23pm
It always amuses us when supporters of the patent system attack our views on patents as being somehow uninformed. Over the years, we've pointed to plenty of rather detailed research on how the patent system tends to hold back innovation -- and how there's no correlation between stronger patent systems and innovation. Usually, when we point this out, the response is to insult us, rather than respond to the research. Fortunately, though, those doing this kind of research keep getting plenty of validation for their work. We've already pointed out that at least one Nobel Laureate in Economics, Joe Stiglitz, has been speaking out on how patents harm innovation. Now comes the news that one of the latest economics Nobel winners has also done research in the space. Evan R.S. writes in to point out that the NY Times article on the winners notes that Nobel winner Eric S. Maskin recent research is on how patents can hold back innovation. The good folks over at Against Monopoly (who include some economists who have been leading the charge in studying this topic) point us to Maskin's paper on this topic. The paper argues that patents tend to harm innovation in high tech fields, mainly because so much innovation is sequential and complementary -- at which point handing out monopolies is guaranteed to slow down the innovation process, because the innovation gets more expensive (need to license any time you do anything), more limiting (because you have to get approval before innovating) and much more time consuming (especially if you have to keep going to court). This isn't a new idea or even new research -- but it's yet another reminder that the economic research continually shows how patents will often hold back innovation, rather than help it.
If you liked this post, you may also be interested in...
- Patent Owner Insists 'Integers' Do Not Include The Number One
- Stanford Professor Insists Consumers Are Helped By Patent Trolls
- Patent Loving East Texas Judge Clips Wings Of Largest Patent Troll
- Techdirt Reading List: The Worldly Philosophers
- Company Acquires Rights To Drug Used By AIDS/Cancer Patients; Immediately Raises Per Pill Price From Under $14 To $750